Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Multimodality evaluation of the viability of stem cells delivered into different zones of myocardial infarction.

Hung TC, Suzuki Y, Urashima T, Caffarelli A, Hoyt G, Sheikh AY, Yeung AC, Weissman I, Robbins RC, Bulte JW, Yang PC.

Circ Cardiovasc Imaging. 2008 Jul;1(1):6-13. doi: 10.1161/CIRCIMAGING.108.767343. Erratum in: Circ Cardiovasc Imaging. 2009 Sep;2(5):e40. Bulte, Jeff M [corrected to Bulte, Jeff W M].

2.

Mechanisms of stem cell effects: insights from MRI.

Rokosh G, Ghafghazi S, Bolli R.

Minerva Cardioangiol. 2013 Dec;61(6):605-16. Review.

PMID:
24253454
3.

Stem cell therapy for chronic myocardial infarction.

Mazo M, Pelacho B, Prósper F.

J Cardiovasc Transl Res. 2010 Apr;3(2):79-88. doi: 10.1007/s12265-009-9159-9. Epub 2010 Jan 21. Review.

PMID:
20560022
4.

Imaging stem cells implanted in infarcted myocardium.

Zhou R, Acton PD, Ferrari VA.

J Am Coll Cardiol. 2006 Nov 21;48(10):2094-106. Epub 2006 Nov 1. Review.

5.

Imaging approaches for the study of cell-based cardiac therapies.

Lau JF, Anderson SA, Adler E, Frank JA.

Nat Rev Cardiol. 2010 Feb;7(2):97-105. doi: 10.1038/nrcardio.2009.227. Epub 2009 Dec 22. Review.

6.

Mending a Faltering Heart.

Li M, Izpisua Belmonte JC.

Circ Res. 2016 Jan 22;118(2):344-51. doi: 10.1161/CIRCRESAHA.115.306820. Review.

PMID:
26838318
7.

The role of cardiac ultrasound in stem cell therapy.

Kahn AM, Demaria AN.

J Cardiovasc Transl Res. 2009 Mar;2(1):2-8. doi: 10.1007/s12265-008-9085-2. Epub 2009 Jan 22. Review.

PMID:
20559963
8.

Cell therapy for acute myocardial infarction--where do we go from here?

Traverse JH, Henry TD.

J Cardiovasc Transl Res. 2008 Mar;1(1):64-70. doi: 10.1007/s12265-007-9002-0. Epub 2008 Jan 31. Review.

PMID:
20559959
9.

Adipose-derived stem cells for myocardial infarction.

Mazo M, Gavira JJ, Pelacho B, Prosper F.

J Cardiovasc Transl Res. 2011 Apr;4(2):145-53. doi: 10.1007/s12265-010-9246-y. Epub 2010 Nov 30. Review.

PMID:
21116883
10.

Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network.

Rodriguez-Porcel M, Kronenberg MW, Henry TD, Traverse JH, Pepine CJ, Ellis SG, Willerson JT, Moyé LA, Simari RD.

JACC Cardiovasc Imaging. 2012 May;5(5):559-65. doi: 10.1016/j.jcmg.2011.12.018. Review.

11.

The diagnostic value of iron oxide nanoparticles for imaging of myocardial inflammation--quo vadis?

Bietenbeck M, Florian A, Sechtem U, Yilmaz A.

J Cardiovasc Magn Reson. 2015 Jul 8;17:54. doi: 10.1186/s12968-015-0165-6. Review.

12.

Preconditioning and stem cell survival.

Haider HKh, Ashraf M.

J Cardiovasc Transl Res. 2010 Apr;3(2):89-102. doi: 10.1007/s12265-009-9161-2. Epub 2009 Dec 22. Review.

PMID:
20560023
13.

Cell-based therapy for prevention and reversal of myocardial remodeling.

Karantalis V, Balkan W, Schulman IH, Hatzistergos KE, Hare JM.

Am J Physiol Heart Circ Physiol. 2012 Aug 1;303(3):H256-70. doi: 10.1152/ajpheart.00221.2012. Epub 2012 May 25. Review.

14.
15.

Magnetic Nanoparticles for Targeting and Imaging of Stem Cells in Myocardial Infarction.

Santoso MR, Yang PC.

Stem Cells Int. 2016;2016:4198790. doi: 10.1155/2016/4198790. Epub 2016 Apr 3. Review.

Items per page

Supplemental Content

Write to the Help Desk